Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Hydration with a saline solution may protect kidney cells from the
side effects of chemotherapy.
PURPOSE: Randomized phase II trial to compare the effectiveness of glufosfamide with or
without hydration in treating patients who have pancreatic cancer that is metastatic or
cannot be removed by surgery.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC